Literature DB >> 7914891

Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element.

E Caldenhoven1, P Coffer, J Yuan, A Van de Stolpe, F Horn, W Kruijer, P T Van der Saag.   

Abstract

Intercellular adhesion molecule-1 (ICAM-1) is a transmembrane glycoprotein that promotes adhesion in immunological and inflammatory reactions. ICAM-1 is expressed on cells of many lineages and is induced by interleukin-6 (IL-6) and interferon-gamma (IFN-gamma). Functional analysis of ICAM-1 promoter-luciferase constructs in HepG2 cells enabled us to identify a region between -110 and -37 mediating IL-6 and IFN-gamma responsiveness and containing a palindromic IL-6/IFN-gamma response element (pIRE). Site-directed mutagenesis of key nucleotides in the ICAM-1 pIRE abolished the effect of both IL-6 and IFN-gamma stimulation, while this pIRE element was sufficient to confer IL-6 and IFN-gamma responsiveness to a heterologous promoter. We further show by gel retardation analysis that distinct nuclear factors induced by both IL-6 or IFN-gamma specifically bind to this pIRE. Furthermore, treatment with IL-6 results in the formation of multiple complexes while IFN-gamma induces a single binding complex, both in HepG2 and monocytic U937 cells. Differentiation of U937 cells by exposure to 12-O-tetradecanoyl phorbol-13-acetate abolishes response to IL-6 but not IFN-gamma. Supershift data utilizing the ICAM-1 pIRE revealed that IFN-gamma and IL-6 both induce a factor antigenically related to IFN-gamma activation factor. We further provide data suggesting that IL-6 additionally activates an ICAM-1 pIRE binding factor related to the previously described acute-phase response factor in disparate cell types. We therefore conclude that the activation of these related nuclear factors by IL-6 and IFN-gamma is important in the regulation of ICAM-1 gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914891

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Crimean-Congo hemorrhagic fever virus activates endothelial cells.

Authors:  Anne-Marie Connolly-Andersen; Guido Moll; Cecilia Andersson; Sara Akerström; Helen Karlberg; Iyadh Douagi; Ali Mirazimi
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  STAT1 pathway is involved in activation of caprine arthritis-encephalitis virus long terminal repeat in monocytes.

Authors:  T Sepp; S E Tong-Starksen
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.

Authors:  J J Schuringa; L J Jonk; W H Dokter; E Vellenga; W Kruijer
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

Review 4.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

Review 5.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

6.  Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation.

Authors:  P Kovarik; D Stoiber; M Novy; T Decker
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

7.  Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells.

Authors:  Shih-Chung Chen; Ying-Ling Chang; Danny Ling Wang; Jing-Jy Cheng
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 8.  STAT3 inhibitors for cancer therapy: Have all roads been explored?

Authors:  Remi Fagard; Valeri Metelev; Inès Souissi; Fanny Baran-Marszak
Journal:  JAKSTAT       Date:  2013-01-01

Review 9.  STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction.

Authors:  Krzysztof Sikorski; Stefan Chmielewski; Adam Olejnik; Joanna Z Wesoly; Uwe Heemann; Marcus Baumann; Hans Bluyssen
Journal:  JAKSTAT       Date:  2012-10-01

10.  Influence of tumors on protective anti-tumor immunity and the effects of irradiation.

Authors:  Gemma A Foulds; Jürgen Radons; Mira Kreuzer; Gabriele Multhoff; Alan G Pockley
Journal:  Front Oncol       Date:  2013-02-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.